cagrilintide semaglutide combination phase 3 2024 Comparative Effectiveness of CagriSegma, Semaglutide, and Tirzepatide in the Management of Overweight and Obesity: A Network Meta‐Analysis of Randomized Clinical Trials - Hamarsheh - 2026 - Endocrinology, Diabetes & Metabolism We are all anxiously awaiting

Why Demand Keeps Rising (Efficacy, Indications, Awareness) The demand for GLP-1 weight loss drugs continues to surge for a few key reasons

Ozempic is FDA-approved, regulated, and proven to control blood sugar and weight loss

Clinicians should remain vigilant for class-specific adverse effects, including rare but serious complications such as euglycemic diabetic ketoacidosis with SGLT2is and gallbladder disease or pancreatitis with GLP-1RAs [11, 15]

But very rich or greasy meals may feel heavy for some GLP-1 users

10.1111/jocd.15648 164 ManosroiA.PodjanasoonthonK.ManosroiJ

Applications in Functional Medicine Functional medicine practitioners often view immune dysfunction as a root cause of chronic disease